Witte JS - Search Results

1

Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patients.

Levin AM, Lindquist KJ, Avila A, Witte JS, Paris PL, Rybicki BA. Levin AM, et al. Among authors: witte js. Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1677-82. doi: 10.1158/1055-9965.EPI-13-1124. Epub 2014 Jun 2. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24891551 Free PMC article.

2

Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.

Paris PL, Kupelian PA, Hall JM, Williams TL, Levin H, Klein EA, Casey G, Witte JS. Paris PL, et al. Among authors: witte js. Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):901-5. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10548319

3

Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus.

Paris PL, Witte JS, Kupelian PA, Levin H, Klein EA, Catalona WJ, Casey G. Paris PL, et al. Among authors: witte js. Cancer Res. 2000 Jul 1;60(13):3645-9. Cancer Res. 2000. PMID: 10910080

4

Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.

Neville PJ, Conti DV, Paris PL, Levin H, Catalona WJ, Suarez BK, Witte JS, Casey G. Neville PJ, et al. Among authors: witte js. Neoplasia. 2002 Sep-Oct;4(5):424-31. doi: 10.1038/sj.neo.7900254. Neoplasia. 2002. PMID: 12192601 Free PMC article.

5

CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.

Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, Witte JS. Plummer SJ, et al. Among authors: witte js. Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):928-32. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14504207

6

Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2.

Loukola A, Chadha M, Penn SG, Rank D, Conti DV, Thompson D, Cicek M, Love B, Bivolarevic V, Yang Q, Jiang Y, Hanzel DK, Dains K, Paris PL, Casey G, Witte JS. Loukola A, et al. Among authors: witte js. Eur J Hum Genet. 2004 Apr;12(4):321-32. doi: 10.1038/sj.ejhg.5201101. Eur J Hum Genet. 2004. PMID: 14560315

7

DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer.

Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS. Rybicki BA, et al. Among authors: witte js. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):23-9. doi: 10.1158/1055-9965.epi-03-0053. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744728

8

Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR.

Cicek MS, Conti DV, Curran A, Neville PJ, Paris PL, Casey G, Witte JS. Cicek MS, et al. Among authors: witte js. Prostate. 2004 Apr 1;59(1):69-76. doi: 10.1002/pros.10358. Prostate. 2004. PMID: 14991867

9

No association between genetic polymorphisms in IGF-I and IGFBP-3 and prostate cancer.

Li L, Cicek MS, Casey G, Witte JS. Li L, et al. Among authors: witte js. Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):497-8. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15006930 No abstract available.

10

Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.

Cicek MS, Nock NL, Li L, Conti DV, Casey G, Witte JS. Cicek MS, et al. Among authors: witte js. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1331-6. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters